Sunsource Biotechnology Co., Ltd. It was born in the era of the booming development of China's big health industry. It was established in October 2015. As a pioneer in the field of Eucommia biotechnology, we take "technology drives industrial upgrading, innovation leads the future of health" as our development direction. We have build an independent research and development system covering the entire industry chain of Eucommia.
After ten years of core technology research, the company has successfully broken through the technical barriers of extracting active ingredients from Eucommia. We created a cutting-edge process matrix of "supercritical CO₂extraction + membrane separation and purification". Relying on the intelligent production platform with national patent certification, we have pioneered the low-temperature gradient extraction and nanometer-level molecular purification of the essence components of Eucommia leaves. The production efficiency has been greatly improved compared with traditional processes. The high-purity extraction of various active ingredients has become the first leader technology in China, breaking through international standards and setting an innovation benchmark in the field of biomedicine.
The company has always adhered to the research and development concept of "natural essence, technology empowerment". We has established a strategic alliance with top scientific research institutions such as Guizhou University to form an innovative ecology with deep integration of "production, learning, research and application". We has 13 national invention patents for Eucommia ulmoides, and its product matrix covers three major fields: pharmaceutical raw materials, health food raw materials, and cosmetic raw materials. It is exported to more than 20 countries and regions including Europe, America, Japan, and South Korea.
Standing at the forefront of the new era of the big health industry, Sunsource Eucommia Biology is laying out the Eucommia industry value chain with a global vision. It created a closed loop of the entire industry chain from germplasm selection to deep processing. It was injected continuously green technology momentum in human healthy enterprise.
ADVANTAGES
At present, the eucommia leaves products are generally using the method of heating and boiling. This method will result containing more non-active ingredients and impurities in the extract. When the degree is over 80 °C , a large amount of drug components will decompose and lose biological activity. The eucommia tea and other beverage products are from young immature leaves, which are lack of content of innate pharmacophores. So the effect shows slowly.
After years of painstaking research and development and high investment by our technical team, we finally succeeded in developing a unique technology low-temperature extraction technology, so that the content of active ingredients: the concentration of active ingredients and the consistency of the batch, through the heavy metals, pesticide residues, microbial and other tests to ensure the high purity of the natural ingredients and safety; health care efficacy of a variety of (such as tonifying the liver and kidneys, strengthen the bones and muscles, anti-fatigue, regulating the heart and blood).
A good product cannot be separated from a excellent place of origin. Cautious supervision of raw material sources and high quality screening methods allow us to ensure that from the selection of eucommia leaves to the production of finished products, the process of eucommia leaves are not adulterated with the use of any chemicals, low-consumption and environmentally friendly extraction, to maximise the access to the active ingredients of the eucommia leaves by keeping the leaves in their native state as much as possible. Abandoning the cumbersome process of high-temperature decoction of the original leaves used in the industry, we provide a time-saving, hygienic and efficient way of use only 1-2g of easily-absorbable eucommia extract powder to achieve sufficient efficacy.
